Literature DB >> 16909212

The Foxa family of transcription factors in development and metabolism.

J R Friedman1, K H Kaestner.   

Abstract

The Foxa subfamily of winged helix/forkhead box (Fox) transcription factors has been the subject of genetic and biochemical study for over 15 years. During this time its three members, Foxa1, Foxa2 and Foxa3, have been found to play important roles in multiple stages of mammalian life, beginning with early development, continuing during organogenesis, and finally in metabolism and homeostasis in the adult. Foxa2 is required for the formation of the node and notochord, and in its absence severe defects in gastrulation, neural tube patterning, and gut morphogenesis result in embryonic lethality. Foxa1 and Foxa2 cooperate to establish competence in foregut endoderm and are required for normal development of endoderm-derived organs such as the liver, pancreas, lungs, and prostate. In post-natal life, members of the Foxa family control glucose metabolism through the regulation of multiple target genes in the liver, pancreas, and adipose tissue. Insight into the unique molecular basis of Foxa function has been obtained from recent genetic and genomic data, which identify the Foxa proteins as 'pioneer factors' whose binding to promoters and enhancers enable chromatin access for other tissue-specific transcription factors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16909212     DOI: 10.1007/s00018-006-6095-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  212 in total

1.  A genome-wide analysis of open chromatin in human tracheal epithelial cells reveals novel candidate regulatory elements for lung function.

Authors:  Jared M Bischof; Christopher J Ott; Shih-Hsing Leir; Nehal Gosalia; Lingyun Song; Darin London; Terrence S Furey; Calvin U Cotton; Gregory E Crawford; Ann Harris
Journal:  Thorax       Date:  2011-12-14       Impact factor: 9.139

2.  Foxa1 and Foxa2 maintain the metabolic and secretory features of the mature beta-cell.

Authors:  Nan Gao; John Le Lay; Wei Qin; Nicolai Doliba; Jonathan Schug; Alan J Fox; Olga Smirnova; Franz M Matschinsky; Klaus H Kaestner
Journal:  Mol Endocrinol       Date:  2010-06-09

3.  Epigenetic mechanisms involved in developmental nutritional programming.

Authors:  Anne Gabory; Linda Attig; Claudine Junien
Journal:  World J Diabetes       Date:  2011-10-15

4.  Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer.

Authors:  Zhaoyu Li; Geetu Tuteja; Jonathan Schug; Klaus H Kaestner
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

5.  Information processing at the foxa node of the sea urchin endomesoderm specification network.

Authors:  Smadar Ben-Tabou de-Leon; Eric H Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

Review 6.  Regulation of gene expression in the intestinal epithelium.

Authors:  Camilla A Richmond; David T Breault
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

7.  Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/β-catenin signaling.

Authors:  Hanmin Wang; Jijun Hao; Charles C Hong
Journal:  ACS Chem Biol       Date:  2010-11-24       Impact factor: 5.100

Review 8.  Exploring the emerging complexity in transcriptional regulation of energy homeostasis.

Authors:  Adelheid Lempradl; J Andrew Pospisilik; Josef M Penninger
Journal:  Nat Rev Genet       Date:  2015-10-13       Impact factor: 53.242

9.  Generation of Mouse for Conditional Expression of Forkhead Box A2.

Authors:  Peng Wang; San-Pin Wu; Kelsey E Brooks; Andrew M Kelleher; Jessica J Milano-Foster; Francesco J DeMayo; Thomas E Spencer
Journal:  Endocrinology       Date:  2018-04-01       Impact factor: 4.736

10.  Clinical significance and prognostic value of Forkhead box A1 expression in human epithelial ovarian cancer.

Authors:  Kai Wang; Chenan Guan; Chenyan Fang; Xiaoxiao Jin; Junhui Yu; Yuquan Zhang; Lingzhi Zheng
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.